In the United States, lung disease afflicts more than 20 million patients every year and is one of the leading causes of death. It is often difficult to obtain diagnostic information from these patients because it is difficult to efficiently and non-invasively access the lungs for a quality sample.
We are pioneering the management of lung health through our platform technology, the Cough Collector. The Cough Collector enables easy, rapid, and reliable diagnosis of disease through the non-invasive collection of cough aerosols.
- Deton wins Swimming with the Sharks Competition
Wednesday March 22, 2017
- Deton to be featured at AdvaMed 2016
Saturday October 01, 2016
- Deton selected for RESI X Innovation Challenge
Thursday August 18, 2016
- Deton Corp. Raises $600,000 in Seed Round
Thursday August 04, 2016
- Deton Corp. receives Phase I NIH grant
Friday February 12, 2016